Interventions for preventing oral mucositis for patients with cancer receiving treatment (Q24243046)

25 July 2017

0 references

1 reference

title

Interventions for preventing oral mucositis for patients with cancer receiving treatment (English)

1 reference

25 July 2017

1 reference

1

Helen V Worthington

1 reference

25 July 2017

Martin G McCabe

7

0 references

Anne-Marie Glenny

5

object named as

Anne-Marie Glenny

0 references

Jan Clarkson

2

object named as

Jan E Clarkson

J E Clarkson

1 reference

25 July 2017

Tim OB Eden

3

0 references

O B Eden

3

1 reference

25 July 2017

Gemma Bryan

3

0 references

Susan Furness

4

0 references

Anne Littlewood

6

0 references

Stefan Meyer

8

0 references

Tasneem Khalid

9

0 references

language of work or name

English

0 references

publication date

17 October 2007

1 reference

Cochrane Database of Systematic Reviews

25 July 2017

8 December 2010

0 references

published in

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

12

0 references

page(s)

CD000978

1 reference

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Sucralfate in the prevention of radiation-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effect of oral glutamine supplementation during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucosi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Fluorouracil and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

[Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Management of mucositis in oral irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Mucosal pathology of the upper gastrointestinal tract associated with intensive chemotherapy in children: vitamin A supplements do not prevent lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Interventions for treating oral candidiasis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Oral and intestinal mucositis — causes and possible treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Evidence-based guidelines for managing mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prevention of chemotherapy and radiation toxicity with glutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Treatment-induced mucositis: an old problem with new remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Radiation induced mucositis: co-ordinating a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Interventions for treating oral mucositis for patients with cancer receiving treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

High-dose therapy with combined 5-fluorouracil and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Mucositis prevention by improved dental care in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Mouth care for nasopharyngeal cancer patients undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, ran

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Protection from Radiation-Induced Oral Mucositis by Misoprostol, a Prostaglandin E(1) Analog: A Placebo-Controlled, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Radiation mucositis: a new approach to prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB3

7 January 2021

10.1002/14651858.CD000978.PUB3

Identifiers

DOI

1 reference

25 July 2017

1 reference